• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Is Treatment for Urinary Incontinence Associated with Improved Sleep Quality?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • An important complication of urgency urinary incontinence is sleep disruption
  • Approximately 20 to 45% of reproductive-age woman void ≥1 per night, with this number increasing to 75% in women 70 years of age and above
  • Limited data as to whether improving UUI also positively impacts sleep
  • Warsi et al. (Obstetrics & Gynecology, 2018) studied the impact on UUI treatment and sleep quality

METHODS:

  • A secondary analysis of a multicenter, double-blind, 12-week randomized trial
  • Women were self-diagnosed for UUI frequency and UI subtypes (urgency, stress, other) of any urinary incontinence and based on the 3-Incontinence Questions questionnaire
  • Patients were assigned randomly to
    • 4–8 mg fesoterodine (antimuscarinic) therapy daily
    • Placebo
  • At baseline and 12 weeks, participants completed:
    • A validated voiding diary to evaluate incontinence and voiding symptoms
    • The Pittsburgh Sleep Quality Index to evaluate sleep quality
    • The Epworth Sleepiness Scale to evaluate daytime sleepiness

 RESULTS:

  • Data was collected from 645 subjects
  • 322 women were randomized to antimuscarinic and 323 to placebo
  • Follow-up data was availabe for 303 (94.4%) women in the antimuscarinic group and 301 (93.2%) in the placebo group
  • Mean (SD) age was 56 (±14) years, 68% were white, and 57% had poor sleep quality
  • Mean frequency of any urinary incontinence and UUI was 4.6 and 3.9 episodes per day, respectively
  • After 12 weeks, the anti-muscarinic group compared to placebo reported
    • A greater decrease in UUI frequency of 0.88 episodes/d (P<.001)
    • A greater decrease in diurnal and nocturnal voiding frequency (P<.05)
  • A greater improvement in sleep quality (total Pittsburgh Sleep Quality Index score 0.48; P=.02)
  • A greater improvement in sleep duration and sleep efficiency subscales (P<.05)
  • The intervention did not affect daytime sleepiness

CONCLUSION:

  • UUI medical treatment leads to decreased incontinence frequency, nocturia, and improved sleep quality

Learn More – Primary Sources:

Association of Pharmacologic Treatment of Urgency Urinary Incontinence With Sleep Quality and Daytime Sleepiness

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

AUGS Statement on Anticholinergic Medications for Overactive Bladder and Dementia Risk
Urinary Incontinence – How to Make the Diagnosis in Your Office and When to Refer
Practical info for your gynecology practice
Treating Urinary Incontinence Without Surgery: Options and Pearls

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site